RT Journal Article
SR Electronic
T1 PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007829
DO 10.1136/jitc-2023-007829
VO 12
IS 1
A1 Moraes Ribeiro, Emmanuelle
A1 Secker, Kathy-Ann
A1 Nitulescu, Ana-Maria
A1 Schairer, Rebekka
A1 Keppeler, Hildegard
A1 Wesle, Anton
A1 Schmid, Hannes
A1 Schmitt, Anita
A1 Neuber, Brigitte
A1 Chmiest, Daniela
A1 Podavini, Silvia
A1 Märklin, Melanie
A1 Klimovich, Boris
A1 Schmitt, Michael
A1 Korkmaz, Fulya
A1 Lengerke, Claudia
A1 Schneidawind, Corina
A1 Schneidawind, Dominik
YR 2024
UL http://jitc.bmj.com/content/12/1/e007829.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.